Wegovy 0.25 mg Flextouch: injectable solution for weight loss
Introducing Wegovy 0.25 mg
Wegovy 0.25 mg Flextouch is an injectable treatment containing semaglutide, developed by Novo Nordisk to help overweight or obese adults achieve sustainable weight loss. This medication acts on GLP-1, a natural hormone that controls appetite and satiety. By reducing hunger and slowing gastric emptying, Wegovy 0.25 mg promotes gradual weight loss while regulating blood sugar levels.
STEP clinical studies have shown an average reduction of 15% in body weight after 68 weeks when combined with a low-calorie diet and regular physical activity.
Wegovy 0.25 mg price and availability
The price of wegovy Flextouch 0.25 mg costs between €250 and €320 depending on the pharmacy. It is sold in a pre-filled 1,5 ml pen containing four doses. Treatment begins at 0.25 mg before being gradually increased (0.5 mg, 1 mg, 1.7 mg, then 2.4 mg). This regimen helps to limit gastrointestinal side effects.
Wegovy is not reimbursed in France, but several approved medical platforms allow online prescription and secure delivery.
Wegovy 0.25 mg user and doctor reviews
Reviews of Wegovy 0.25 mg weight loss are generally positive.
Patients report a reduction in appetite within the first few weeks and a weight loss of 3 to 5 kg in one month. Doctors confirm its effectiveness, while emphasizing that this is a medical treatment reserved for patients with a BMI over 35 kg/m² and supervised by a healthcare professional.
Dr. Emmanuel Disse, an endocrinologist, explains: “Wegovy is transforming the management of obesity. It allows for lasting results, but its use must remain medically supervised.”
Common side effects
The most commonly reported side effects are:
- Mild nausea
- Constipation
- bloating
- Moderate fatigue
These effects diminish over time and good hydration helps to reduce them.
Summary table
| DOSE | PERIOD | PRIMARY OBJECTIVE |
|---|---|---|
| 0.25 mg | Weeks 1 to 4 | Starting the treatment |
| 0.5 mg | Weeks 5 to 8 | Gradual adaptation |
| 1mg to 2.4mg | After 9 weeks | Stabilization and lasting loss |
FAQ
1. When will the first results be seen?
The first effects appear in 3 to 4 weeks.
2. Is Wegovy 0.25 mg covered by insurance?
No, it is currently not reimbursed.
3. Is a prescription required?
Yes, Wegovy requires a medical prescription.
4. Is it suitable for diabetics?
Yes, except for type 1 diabetics.
Wegovy 0.25 mg Flextouch is a modern, scientifically validated solution to support sustainable weight loss and improve metabolic health.
Related products
WEGOVY
WEGOVY
WEGOVY
WEGOVY